Few days left before the ESMO Congress 2019 - starting on Friday 27 September - Dr Markus Joerger from Kantonsspital St.Gallen, Switzerland, gives a little preview of the main outcomes coming from the annual event. Beyond updates on how to treat 'big killers' in oncology, promising results are also expected for some difficult-to-treat malignancies for which few options of care are available.
Clinical advances in difficult to treat tumours are awaited at ESMO 2019
